285 related articles for article (PubMed ID: 14716751)
21. Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells.
Kiss L; Walter FR; Bocsik A; Veszelka S; Ozsvári B; Puskás LG; Szabó-Révész P; Deli MA
J Pharm Sci; 2013 Apr; 102(4):1173-81. PubMed ID: 23362123
[TBL] [Abstract][Full Text] [Related]
22. Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity.
Dudeja PK; Anderson KM; Harris JS; Buckingham L; Coon JS
Arch Biochem Biophys; 1995 May; 319(1):309-15. PubMed ID: 7771801
[TBL] [Abstract][Full Text] [Related]
23. Metabolic inhibition and kinetics of raloxifene by pharmaceutical excipients in human liver microsomes.
Kim AR; Lim SJ; Lee BJ
Int J Pharm; 2009 Feb; 368(1-2):37-44. PubMed ID: 18977285
[TBL] [Abstract][Full Text] [Related]
24. Suitability of commonly used excipients for electrophysiological in-vitro safety pharmacology assessment of effects on hERG potassium current and on rabbit Purkinje fiber action potential.
Himmel HM
J Pharmacol Toxicol Methods; 2007; 56(2):145-58. PubMed ID: 17590357
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of Action of Panaxytriol on Midazolam 1'-Hydroxylation and 4-Hydroxylation Mediated by CYP3A in Liver Microsomes and Rat Primary Hepatocytes.
He F; Zhang W; Zeng C; Xia C; Xiong Y; Zhang H; Huang S; Liu M
Biol Pharm Bull; 2015; 38(10):1470-7. PubMed ID: 26424012
[TBL] [Abstract][Full Text] [Related]
26. Comparison of intrinsic clearance in liver microsomes and hepatocytes from rats and humans: evaluation of free fraction and uptake in hepatocytes.
Lu C; Li P; Gallegos R; Uttamsingh V; Xia CQ; Miwa GT; Balani SK; Gan LS
Drug Metab Dispos; 2006 Sep; 34(9):1600-5. PubMed ID: 16790553
[TBL] [Abstract][Full Text] [Related]
27. In situ controlled crystallization as a tool to improve the dissolution of Glibenclamide.
Elkordy AA; Jatto A; Essa E
Int J Pharm; 2012 May; 428(1-2):118-20. PubMed ID: 22426322
[TBL] [Abstract][Full Text] [Related]
28. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
[TBL] [Abstract][Full Text] [Related]
29. Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes.
Szotáková B; Skálová L; Baliharová V; Dvorscáková M; Storkánová L; Sispera L; Wsól V
J Pharm Pharmacol; 2004 Feb; 56(2):205-12. PubMed ID: 15005879
[TBL] [Abstract][Full Text] [Related]
30. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion.
Khoee S; Yaghoobian M
Eur J Med Chem; 2009 Jun; 44(6):2392-9. PubMed ID: 19010570
[TBL] [Abstract][Full Text] [Related]
31. Effect of paclitaxel and Cremophor EL on mast cell histamine secretion and their interaction with adriamycin.
Decorti G; Bartoli Klugmann F; Candussio L; Baldini L
Anticancer Res; 1996; 16(1):317-20. PubMed ID: 8615628
[TBL] [Abstract][Full Text] [Related]
32. Effect of polyoxyl 35 castor oil and Polysorbate 80 on the intestinal absorption of digoxin in vitro.
Cornaire G; Woodley JF; Saivin S; Legendre JY; Decourt S; Cloarec A; Houin G
Arzneimittelforschung; 2000 Jun; 50(6):576-9. PubMed ID: 10918954
[TBL] [Abstract][Full Text] [Related]
33. The effect of novel surfactants and Solutol HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer.
Alani AW; Rao DA; Seidel R; Wang J; Jiao J; Kwon GS
J Pharm Sci; 2010 Aug; 99(8):3473-85. PubMed ID: 20198687
[TBL] [Abstract][Full Text] [Related]
34. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
Friche E; Jensen PB; Sehested M; Demant EJ; Nissen NN
Cancer Commun; 1990; 2(9):297-303. PubMed ID: 1976341
[TBL] [Abstract][Full Text] [Related]
35. Water-soluble organic solubilizers for in vitro drug delivery studies with respiratory epithelial cells: selection based on various toxicity indicators.
MacDonald C; Lyzenga W; Shao D; Agu RU
Drug Deliv; 2010 Aug; 17(6):434-42. PubMed ID: 20429851
[TBL] [Abstract][Full Text] [Related]
36. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
Nornoo AO; Osborne DW; Chow DS
Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
[TBL] [Abstract][Full Text] [Related]
38. Paclitaxel nanoparticles for the potential treatment of brain tumors.
Koziara JM; Lockman PR; Allen DD; Mumper RJ
J Control Release; 2004 Sep; 99(2):259-69. PubMed ID: 15380635
[TBL] [Abstract][Full Text] [Related]
39. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
Kharasch ED; Walker A; Hoffer C; Sheffels P
Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of taxol by human and rat liver in vitro: a screen for drug interactions and interspecies differences.
Jamis-Dow CA; Klecker RW; Katki AG; Collins JM
Cancer Chemother Pharmacol; 1995; 36(2):107-14. PubMed ID: 7767945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
